O'Dell Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

O'Dell Group’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-7,745	Closed	-$1.69M	–	82
2021 Q1	$1.69M	Buy	+7,745	New	+$1.33M	0.59%	19
2019 Q3	–	Sell	-60,039	Closed	-$8.46M	–	57
2019 Q2	$8.46M	Buy	60,039 +3,732	+7%	+$515K	5.13%	9
2019 Q1	$8.49M	Sell	56,307 -33	-0.1%	-$4.75K	5.36%	9
2018 Q4	$7M	Sell	56,340 -3,357	-6%	-$459K	5.15%	9
2018 Q3	$9.46M	Buy	+59,697	New	+$9.03M	6.11%	9

Other funds holding FBT

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

O'Dell Group's FBT Position: Q2 2021 in Review

O'Dell Group sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2021, closing a stake of 7,745 shares — an estimated $1.69M sold.

O'Dell Group first reported a position in FBT in Q3 2018 and held it in 5 quarters. The position peaked at $9.46M in Q3 2018. 233 funds tracked by Wall St. Rank hold FBT as of Q2 2021.

O'Dell Group reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2021 after selling out during the quarter.
O'Dell Group sold 7,745 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2021, an estimated $1.69M.
O'Dell Group first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2018 and held it in 5 quarters.
O'Dell Group's First Trust NYSE Arca Biotechnology Index Fund position peaked at $9.46M in Q3 2018.
233 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2021.

Based on O'Dell Group's 13F filing for Q2 2021, filed 12 Aug 2021.